関連する実験動画

Updated: May 5, 2026

Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method

Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method

Published on: May 12, 2023

ダンシェン-ホンフアハーブペア:化学成分,薬理学,臨床応用,品質管理,t-コプル機能分析に関するレビュー

Qingrong Zhao¹, Daixin Yu¹, Tingting Lan¹

¹State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, 210023, China; School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.

Journal of ethnopharmacology

|August 28, 2025

まとめ

ダンシェン・ホンフア (DS-HH) は,心血管疾患に有効な伝統的な中国薬草のペアです. このレビューでは,その化合物,薬理学,品質管理の詳細が示され,その相乗効果の治療の可能性が確認されています.

科学分野:

中国伝統医学 (TCM)
薬理学について
薬草の薬

背景:

ダンシェン・ホンホワ (DS-HH) は,TCMの処方箋における重要なハーブペアである.
血液循環を活性化し,静止状態を解消する作用があることが知られている.
心血管疾患と脳血管疾患の治療に重要な有効性を示しています.

研究の目的:

DS-HHハーブペアの伝統的な用途,化学成分,および薬理学的活動を体系的に検討する.
DS-HHの品質管理方法を要約する.
DS-HHの臨床適用に関するガイドラインを提示する.

主な方法:

PubMed,CNKI,TCM WIKI,ETCMを含むデータベースの包括的な文献検索
キーワードは"Salvia miltiorrhiza", "Carthamus", "Danshen-Honghua", "化学組成", "薬理学的作用", "薬理学", "品質管理"でした.
データ分析には,ドースカップリング効果のためのt-copulaモデリングが含まれています.

主要な成果:

DS-HHには,547の特徴づけられた化合物が含まれており,ヒドロキシサッフロール黄色A,サルビアノール酸B,タンシノンIIA,ダンセンシュなどの主要成分が含まれています.
薬理学的効果には,心臓保護,抗血小板凝集,神経保護,脂質低下,血管内皮細胞保護が含まれています.
併用は活性化合物の吸収と分布を高め,同時にクリアランスを低下させ,治療効果を高めます. 品質管理はQマーカー,指紋,QAMSを使用しています.

結論:

このレビューは,DS-HHの物質的基盤とシナジスティックメカニズムを明らかにします.
これらの発見は,心臓血管および脳血管疾患に対するDS-HHの治療の可能性を裏付けています.
DS- HHは,強化された薬理学プロファイルと多標的の薬理学的作用を示しています.

キーワード:

化学成分ダンシェン・ホンフアハーブペア薬理学薬理学について品質管理

さらに関連する動画

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis

Published on: December 8, 2023

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry

Published on: February 2, 2024

関連する概念動画

Drug Concentrations: Measurements

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...